Showing results (31-40 of 635) with videos related to
Sort By:
Pageof 64
Expert Opinion on Pharmacotherapy|April 9, 2013
Current pharmacotherapeutical options for the prevention of kidney transplant rejectionSebastian M Schaefer, Caner Süsal, Claudia Sommerer, et al.BMC Nephrology|December 28, 2018
Gender disparity in health-related quality of life and fatigue after living renal donationClaudia Sommerer, Sarah Estelmann, Nicole G Metzendorf, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 7, 2006
Late referral--a major cause of poor outcome in the very elderly dialysis patientVedat Schwenger, Christian Morath, Alex Hofmann, et al.Therapeutic Drug Monitoring|July 12, 2011
Pharmacodynamic disparities in tacrolimus-treated patients developing cytomegalus virus viremiaClaudia Sommerer, Martin Zeier, David Czock, et al.Clinical Transplantation|April 9, 2008
Pharmacodynamic immune monitoring of NFAT-regulated genes predicts skin cancer in elderly long-term renal transplant recipientsClaudia Sommerer, Wolfgang Hartschuh, Alexander Enk, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 2, 2006
Comprehensive immunohistological analysis of the endothelin system in human kidney graftsKathrin Frank, Martin Zeier, Marie-Luise Gross, et al.Journal of Hypertension|October 16, 2008
Switch of immunosuppression from cyclosporine A to everolimus: impact on pulse wave velocity in stable de-novo renal allograft recipientsJoerg Seckinger, Claudia Sommerer, Ulrich-Paul Hinkel, et al.Pediatric Transplantation|July 7, 2010
Pharmacodynamic monitoring of cyclosporine A by NFAT-regulated gene expression and the relationship with infectious complications in pediatric renal transplant recipientsHeiko Billing, Thomas Giese, Claudia Sommerer, et al.Clinical Transplantation|June 6, 2017
Switch to an everolimus-facilitated cyclosporine A sparing immunosuppression improves glycemic control in selected kidney transplant recipientsFlorian Kälble, Jörg Seckinger, Matthias Schaier, et al.Transplant Immunology|October 2, 2012
Methylprednisolone treatment increases the proportion of the highly suppressive HLA-DR(+)-Treg-cells in transplanted patientsNicole Seissler, Edgar Schmitt, Friederike Hug, et al.Pageof 64